The number and complexity of regulatory documents has increased significantly in the last decade as the volume of clinical trials and the regulatory burden have grown. The expedited clinical research for Covid -19 vaccines and therapeutics has further demonstrated the need for rapidly generating high quality regulatory documents to ensure patient safety and data integrity. As the pharmaceutical industry steps up to meet these expectations, an effective and efficient document quality control process can play an important role in ensuring the submission of high quality documents to strict timelines.
In this webinar, our speakers will discuss the drivers for dedicated quality control in medical writing, providing a sponsor’s and vendor’s perspective on quality, cost to achieve quality medical writing documents, benefits of deploying dedicated quality control reviewers and the need for heightened quality during the current pandemic.
Join this free webinar to learn more about the value of dedicated quality control in medical writing.